{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T17:36:22Z","timestamp":1771263382572,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pulmonary alveolar proteinosis is a rare interstitial lung disease characterized by accumulating surfactant materials in the alveoli. The autoimmune form is by far the most common in adults, while in the pediatric age group, the vast majority of cases are congenital. We report a case of an adolescent patient diagnosed with autoimmune pulmonary alveolar proteinosis, which is unusual in this age group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A-15 year-old Saudi male presented to the emergency department with a history of shortness of breath and low oxygen saturation. High-resolution computed tomography of his chest showed a global crazy-paving pattern. Autoantibodies against granulocyte-macrophage colony-stimulating factor were detected in his serum. A diagnosis of the autoimmune form of pulmonary alveolar proteinosis was confirmed after excluding other possible causes. The patient improved after he underwent whole lung lavage under general anesthesia, and he was independent of oxygen therapy after 6\u00a0months of follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The autoimmune form of pulmonary alveolar proteinosis is rare in the pediatric age group and should be considered when no apparent cause of this disease was found. Whole lung lavage should be the first treatment modality offered in this setting with close follow-up and monitoring.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-021-02906-2","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T23:04:47Z","timestamp":1625785487000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Autoimmune pulmonary alveolar proteinosis successfully treated with lung lavage in an adolescent patient: a case report"],"prefix":"10.1186","volume":"15","author":[{"given":"Abdalla Mohmed","family":"Alasiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7464-3637","authenticated-orcid":false,"given":"Reem Abdullah","family":"Alasbali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meaad Ali","family":"Alaqil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aishah Marei","family":"Alahmari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nouf Dagash","family":"Alshamrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabab Nasir","family":"Badri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,9]]},"reference":[{"issue":"7","key":"2906_CR1","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/S2213-2600(18)30043-2","volume":"6","author":"A Kumar","year":"2018","unstructured":"Kumar A, Abdelmalak B, Inoue Y, Culver DA. Pulmonary alveolar proteinosis in adults: pathophysiology and clinical approach. Lancet Respir Med. 2018;6(7):554\u201365. https:\/\/doi.org\/10.1016\/S2213-2600(18)30043-2.","journal-title":"Lancet Respir Med"},{"issue":"3","key":"2906_CR2","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ccm.2016.04.006","volume":"37","author":"T Suzuki","year":"2016","unstructured":"Suzuki T, Trapnell BC. Pulmonary alveolar proteinosis syndrome. Clin Chest Med. 2016;37(3):431\u201340. https:\/\/doi.org\/10.1016\/j.ccm.2016.04.006.","journal-title":"Clin Chest Med"},{"issue":"2","key":"2906_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.clim.2010.02.017","volume":"135","author":"B Carey","year":"2010","unstructured":"Carey B, Trapnell BC. The molecular basis of pulmonary alveolar proteinosis. Clin Immunol. 2010;135(2):223\u201335. https:\/\/doi.org\/10.1016\/j.clim.2010.02.017.","journal-title":"Clin Immunol"},{"issue":"1","key":"2906_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13023-018-0846-y","volume":"13","author":"C McCarthy","year":"2018","unstructured":"McCarthy C, Avetisyan R, Carey BC, Chalk C, Trapnell BC. Prevalence and healthcare burden of pulmonary alveolar proteinosis. Orphanet J Rare Dis. 2018;13(1):129. https:\/\/doi.org\/10.1186\/s13023-018-0846-y.","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"2906_CR5","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1164\/rccm.201002-0271OC","volume":"182","author":"T Suzuki","year":"2010","unstructured":"Suzuki T, Sakagami T, Young LR, Carey BC, Wood RE, Luisetti M, et\u00a0al. Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy. Am J Respir Crit Care Med. 2010;182(10):1292\u2013304. https:\/\/doi.org\/10.1164\/rccm.201002-0271OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"2906_CR6","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1164\/rccm.200708-1271OC","volume":"177","author":"Y Inoue","year":"2008","unstructured":"Inoue Y, Trapnell BC, Tazawa R, Arai T, Takada T, Hizawa N, et\u00a0al. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med. 2008;177(7):752\u201362. https:\/\/doi.org\/10.1164\/rccm.200708-1271OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"2906_CR7","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1378\/chest.114.5.1357","volume":"114","author":"LS Goldstein","year":"1998","unstructured":"Goldstein LS, Kavuru MS, Curtis-McCarthy P, Christie HA, Farver C, Stoller JK. Pulmonary alveolar proteinosis: clinical features and outcomes. Chest. 1998;114(5):1357\u201362. https:\/\/doi.org\/10.1378\/chest.114.5.1357.","journal-title":"Chest"},{"key":"2906_CR8","unstructured":"Nogee LM, III FSC, Hamvas A. Diffuse Lung Diseases in Childhood. In: Kliegman R. M., Stan B. F., III J. W. S. G., Schor N. F., editors. Nelson Textbook of Pediatrics. 2. 20 ed. Philadelphia, PA: Elsevier, Inc.; 2016. p. 2116-20."},{"issue":"23","key":"2906_CR9","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1056\/NEJM195806052582301","volume":"258","author":"SH Rosen","year":"1958","unstructured":"Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med. 1958;258(23):1123\u201342. https:\/\/doi.org\/10.1056\/NEJM195806052582301.","journal-title":"N Engl J Med"},{"issue":"1","key":"2906_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-019-0066-3","volume":"5","author":"BC Trapnell","year":"2019","unstructured":"Trapnell BC, Nakata K, Bonella F, Campo I, Griese M, Hamilton J, et\u00a0al. Pulmonary alveolar proteinosis. Nat Rev Dis Primers. 2019;5(1):16. https:\/\/doi.org\/10.1038\/s41572-019-0066-3.","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"2906_CR11","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1159\/000101347","volume":"91","author":"A Hamvas","year":"2007","unstructured":"Hamvas A, Cole FS, Nogee LM. Genetic disorders of surfactant proteins. Neonatology. 2007;91(4):311\u20137. https:\/\/doi.org\/10.1159\/000101347.","journal-title":"Neonatology"},{"issue":"2","key":"2906_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1183\/09031936.00092910","volume":"37","author":"H Ishii","year":"2011","unstructured":"Ishii H, Tazawa R, Kaneko C, Saraya T, Inoue Y, Hamano E, et\u00a0al. Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan. Eur Respir J. 2011;37(2):465\u20138. https:\/\/doi.org\/10.1183\/09031936.00092910.","journal-title":"Eur Respir J"},{"key":"2906_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1542\/peds.2017-0610","volume":"140","author":"M Griese","year":"2017","unstructured":"Griese M. Pulmonary alveolar proteinosis: a comprehensive clinical perspective. Pediatrics. 2017;140:2. https:\/\/doi.org\/10.1542\/peds.2017-0610.","journal-title":"Pediatrics."},{"issue":"2","key":"2906_CR14","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1378\/chest.111.2.460","volume":"111","author":"BM Wang","year":"1997","unstructured":"Wang BM, Stern EJ, Schmidt RA, Pierson DJ. Diagnosing pulmonary alveolar proteinosis. A review and an update. Chest. 1997;111(2):460\u20136. https:\/\/doi.org\/10.1378\/chest.111.2.460 ((PubMed PMID: 9041997)).","journal-title":"Chest."},{"issue":"4","key":"2906_CR15","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.hoc.2018.04.004","volume":"32","author":"LJ McReynolds","year":"2018","unstructured":"McReynolds LJ, Calvo KR, Holland SM. Germline GATA2 mutation and bone marrow failure. Hematol Oncol Clin North Am. 2018;32(4):713\u201328. https:\/\/doi.org\/10.1016\/j.hoc.2018.04.004.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"6","key":"2906_CR16","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","volume":"123","author":"MA Spinner","year":"2014","unstructured":"Spinner MA, Sanchez LA, Hsu AP, Shaw PA, Zerbe CS, Calvo KR, et\u00a0al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood. 2014;123(6):809\u201321. https:\/\/doi.org\/10.1182\/blood-2013-07-515528.","journal-title":"Blood"},{"issue":"2","key":"2906_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/bjh.13317","volume":"169","author":"M Collin","year":"2015","unstructured":"Collin M, Dickinson R, Bigley V. Haematopoietic and immune defects associated with GATA2 mutation. Br J Haematol. 2015;169(2):173\u201387. https:\/\/doi.org\/10.1111\/bjh.13317.","journal-title":"Br J Haematol"},{"issue":"1","key":"2906_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/ACI.0000000000000126","volume":"15","author":"AP Hsu","year":"2015","unstructured":"Hsu AP, McReynolds LJ, Holland SM. GATA2 deficiency. Curr Opin Allergy Clin Immunol. 2015;15(1):104\u20139. https:\/\/doi.org\/10.1097\/ACI.0000000000000126.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"4","key":"2906_CR19","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/cam4.384","volume":"4","author":"MA Mir","year":"2015","unstructured":"Mir MA, Kochuparambil ST, Abraham RS, Rodriguez V, Howard M, Hsu AP, et\u00a0al. Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations. Cancer Med. 2015;4(4):490\u20139. https:\/\/doi.org\/10.1002\/cam4.384.","journal-title":"Cancer Med"},{"issue":"10","key":"2906_CR20","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/ng.913","volume":"43","author":"CN Hahn","year":"2011","unstructured":"Hahn CN, Chong CE, Carmichael CL, Wilkins EJ, Brautigan PJ, Li XC, et\u00a0al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet. 2011;43(10):1012\u20137. https:\/\/doi.org\/10.1038\/ng.913.","journal-title":"Nat Genet"},{"issue":"11","key":"2906_CR21","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1182\/blood-2015-09-669937","volume":"127","author":"MW Wlodarski","year":"2016","unstructured":"Wlodarski MW, Hirabayashi S, Pastor V, Stary J, Hasle H, Masetti R, et\u00a0al. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents. Blood. 2016;127(11):1387\u201397. https:\/\/doi.org\/10.1182\/blood-2015-09-669937.","journal-title":"Blood."},{"issue":"2 Pt 1","key":"2906_CR22","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1164\/ajrccm.162.2.9910032","volume":"162","author":"T Kitamura","year":"2000","unstructured":"Kitamura T, Uchida K, Tanaka N, Tsuchiya T, Watanabe J, Yamada Y, et\u00a0al. Serological diagnosis of idiopathic pulmonary alveolar proteinosis. Am J Respir Crit Care Med. 2000;162(2 Pt 1):658\u201362. https:\/\/doi.org\/10.1164\/ajrccm.162.2.9910032.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1\u20132","key":"2906_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jim.2013.11.011","volume":"402","author":"K Uchida","year":"2014","unstructured":"Uchida K, Nakata K, Carey B, Chalk C, Suzuki T, Sakagami T, et\u00a0al. Standardized serum GM-CSF autoantibody testing for the routine clinical diagnosis of autoimmune pulmonary alveolar proteinosis. J Immunol Methods. 2014;402(1\u20132):57\u201370. https:\/\/doi.org\/10.1016\/j.jim.2013.11.011.","journal-title":"J Immunol Methods"},{"issue":"3","key":"2906_CR24","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1177\/1066896919870598","volume":"28","author":"S Shivji","year":"2020","unstructured":"Shivji S, Amin R, Putra J. Bronchoalveolar lavage findings in a pediatric patient with primary pulmonary alveolar proteinosis. Int J Surg Pathol. 2020;28(3):294\u20135. https:\/\/doi.org\/10.1177\/1066896919870598.","journal-title":"Int J Surg Pathol"},{"key":"2906_CR25","doi-asserted-by":"publisher","first-page":"101100","DOI":"10.1016\/j.rmcr.2020.101100","volume":"30","author":"SG Meka","year":"2020","unstructured":"Meka SG, Mohr M, Nair GB, Salman BA. Autoimmune pulmonary alveolar proteinosis mimicking Mycoplasma pneumonia in an adolescent. Respir Med Case Rep. 2020;30:101100. https:\/\/doi.org\/10.1016\/j.rmcr.2020.101100.","journal-title":"Respir Med Case Rep"},{"key":"2906_CR26","doi-asserted-by":"publisher","DOI":"10.1097\/PEC.0000000000001820","author":"L Feld","year":"2019","unstructured":"Feld L, Jennings J, Fiorino EK, Harris M. Pulmonary alveolar proteinosis: a case of profound hypoxemia in a previously healthy teenager. Pediatr Emerg Care. 2019. https:\/\/doi.org\/10.1097\/PEC.0000000000001820.","journal-title":"Pediatr Emerg Care"},{"key":"2906_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/PEC.0000000000001536","author":"S Sirin Kose","year":"2018","unstructured":"Sirin Kose S, Asilsoy S, Uzuner N, Karaman O, Ozer E, Anal O. Pulmonary alveolar proteinosis in hereditary and autoimmune forms with 2 cases. Pediatr Emerg Care. 2018. https:\/\/doi.org\/10.1097\/PEC.0000000000001536.","journal-title":"Pediatr Emerg Care"},{"key":"2906_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.rmcr.2018.02.005","volume":"23","author":"ME Gajewska","year":"2018","unstructured":"Gajewska ME, Sritharan SS, Santoni-Rugiu E, Bendstrup EM. Autoimmune pulmonary alveolar proteinosis in an adolescent successfully treated with inhaled rhGM-CSF (molgramostim). Respir Med Case Rep. 2018;23:167\u20139. https:\/\/doi.org\/10.1016\/j.rmcr.2018.02.005.","journal-title":"Respir Med Case Rep"},{"key":"2906_CR29","doi-asserted-by":"publisher","unstructured":"Trukalj M, Perica M, Ferencic Z, Erceg D, Navratil M, Redzepi G, et\u00a0al. Successful treatment of autoimmune pulmonary alveolar proteinosis in a pediatric patient. Am J Case Rep. 2016;17:641-5. https:\/\/doi.org\/10.12659\/ajcr.897868","DOI":"10.12659\/ajcr.897868"},{"key":"2906_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.rmcr.2016.06.009","volume":"19","author":"GA Sideris","year":"2016","unstructured":"Sideris GA, Josephson M. Pulmonary alveolar proteinosis and Niemann Pick disease type B: an unexpected combination. Respir Med Case Rep. 2016;19:37\u20139. https:\/\/doi.org\/10.1016\/j.rmcr.2016.06.009.","journal-title":"Respir Med Case Rep"},{"key":"2906_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2012-006987","author":"A Strickler","year":"2014","unstructured":"Strickler A, Boza ML, Koppmann A, Gonzalez S. Autoimmune pulmonary proteinosis in a Chilean teenager, a rare aetiology of interstitial lung disease. BMJ Case Rep. 2014. https:\/\/doi.org\/10.1136\/bcr-2012-006987.","journal-title":"BMJ Case Rep."},{"issue":"3","key":"2906_CR32","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1097\/PCC.0b013e3181b809d6","volume":"11","author":"RM DiBlasi","year":"2010","unstructured":"DiBlasi RM, Crotwell D, Geiduscheck JM, Richardson P, Smith A, Salyer JW, et\u00a0al. Therapeutic bilateral lung lavage in a child with pulmonary alveolar proteinosis. Pediatr Crit Care Med. 2010;11(3):e28-31. https:\/\/doi.org\/10.1097\/PCC.0b013e3181b809d6.","journal-title":"Pediatr Crit Care Med"},{"issue":"3","key":"2906_CR33","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1378\/chest.08-1317","volume":"135","author":"TE Robinson","year":"2009","unstructured":"Robinson TE, Trapnell BC, Goris ML, Quittell LM, Cornfield DN. Quantitative analysis of longitudinal response to aerosolized granulocyte-macrophage colony-stimulating factor in two adolescents with autoimmune pulmonary alveolar proteinosis. Chest. 2009;135(3):842\u20138. https:\/\/doi.org\/10.1378\/chest.08-1317.","journal-title":"Chest"},{"issue":"8","key":"2906_CR34","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1002\/ppul.20856","volume":"43","author":"H Yamamoto","year":"2008","unstructured":"Yamamoto H, Yamaguchi E, Agata H, Kandatsu N, Komatsu T, Kawai S, et\u00a0al. A combination therapy of whole lung lavage and GM-CSF inhalation in pulmonary alveolar proteinosis. Pediatr Pulmonol. 2008;43(8):828\u201330. https:\/\/doi.org\/10.1002\/ppul.20856.","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"2906_CR35","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/ppul.20347","volume":"41","author":"A Price","year":"2006","unstructured":"Price A, Manson D, Cutz E, Dell S. Pulmonary alveolar proteinosis associated with anti-GM-CSF antibodies in a child: successful treatment with inhaled GM-CSF. Pediatr Pulmonol. 2006;41(4):367\u201370. https:\/\/doi.org\/10.1002\/ppul.20347.","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"2906_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/thx.2004.021329","volume":"60","author":"P Latzin","year":"2005","unstructured":"Latzin P, Tredano M, Wust Y, de Blic J, Nicolai T, Bewig B, et\u00a0al. Anti-GM-CSF antibodies in paediatric pulmonary alveolar proteinosis. Thorax. 2005;60(1):39\u201344. https:\/\/doi.org\/10.1136\/thx.2004.021329.","journal-title":"Thorax"},{"issue":"5","key":"2906_CR37","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1055\/s-0032-1325160","volume":"33","author":"T Wang","year":"2012","unstructured":"Wang T, Lazar CA, Fishbein MC, Lynch JP 3rd. Pulmonary alveolar proteinosis. Semin Respir Crit Care Med. 2012;33(5):498\u2013508. https:\/\/doi.org\/10.1055\/s-0032-1325160.","journal-title":"Semin Respir Crit Care Med."},{"issue":"6","key":"2906_CR38","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1164\/arrd.1978.117.6.1059","volume":"117","author":"RJ Martin","year":"1978","unstructured":"Martin RJ, Rogers RM, Myers NM. PUlmonary alveolar proteinosis: shunt fraction and lactic acid dehydrogenase concentration as aids to diagnosis. Am Rev Respir Dis. 1978;117(6):1059\u201362. https:\/\/doi.org\/10.1164\/arrd.1978.117.6.1059 ((PubMed PMID: 666104)).","journal-title":"Am Rev Respir Dis."},{"issue":"3","key":"2906_CR39","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/thorax.58.3.252","volume":"58","author":"JF Seymour","year":"2003","unstructured":"Seymour JF, Doyle IR, Nakata K, Presneill JJ, Schoch OD, Hamano E, et\u00a0al. Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis. Thorax. 2003;58(3):252\u20137. https:\/\/doi.org\/10.1136\/thorax.58.3.252.","journal-title":"Thorax"},{"issue":"1","key":"2906_CR40","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1148\/radiology.211.1.r99ap10155","volume":"211","author":"T Johkoh","year":"1999","unstructured":"Johkoh T, Itoh H, M\u00fcller NL, Ichikado K, Nakamura H, Ikezoe J, et\u00a0al. Crazy-paving appearance at thin-section CT: spectrum of disease and pathologic findings. Radiology. 1999;211(1):155\u201360. https:\/\/doi.org\/10.1148\/radiology.211.1.r99ap10155.","journal-title":"Radiology"},{"issue":"5","key":"2906_CR41","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1155\/2006\/203830","volume":"13","author":"N Maimon","year":"2006","unstructured":"Maimon N, Paul N, Downey GP. Progressive dyspnea associated with a crazy-paving appearance on a chest computed tomography scan. Can Respir J. 2006;13(5):269\u201371. https:\/\/doi.org\/10.1155\/2006\/203830.","journal-title":"Can Respir J"},{"issue":"5","key":"2906_CR42","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1378\/chest.09-0097","volume":"136","author":"H Ishii","year":"2009","unstructured":"Ishii H, Trapnell BC, Tazawa R, Inoue Y, Akira M, Kogure Y, et\u00a0al. Comparative study of high-resolution CT findings between autoimmune and secondary pulmonary alveolar proteinosis. Chest. 2009;136(5):1348\u201355. https:\/\/doi.org\/10.1378\/chest.09-0097.","journal-title":"Chest"},{"issue":"1","key":"2906_CR43","first-page":"117","volume":"97","author":"B Mahut","year":"1996","unstructured":"Mahut B, Delacourt C, Scheinmann P, de Blic J, Mani TM, Fournet JC, et\u00a0al. Pulmonary alveolar proteinosis: experience with eight pediatric cases and a review. Pediatrics. 1996;97(1):117\u201322.","journal-title":"Pediatrics."},{"issue":"5","key":"2906_CR44","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/s0022-3476(72)80143-4","volume":"80","author":"EM Mazyck","year":"1972","unstructured":"Mazyck EM, Bonner JT, Herd HM, Symbas PN. Pulmonary lavage for childhood pulmonary alveolar proteinosis. J Pediatr. 1972;80(5):839\u201342. https:\/\/doi.org\/10.1016\/s0022-3476(72)80143-4 ((PubMed PMID: 5018397)).","journal-title":"J Pediatr."},{"issue":"2","key":"2906_CR45","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1164\/rccm.2109105","volume":"166","author":"JF Seymour","year":"2002","unstructured":"Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med. 2002;166(2):215\u201335. https:\/\/doi.org\/10.1164\/rccm.2109105.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"2906_CR46","doi-asserted-by":"publisher","first-page":"e1671","DOI":"10.1097\/MJT.0000000000000239","volume":"23","author":"HT Zhang","year":"2016","unstructured":"Zhang HT, Wang C, Wang CY, Fang SC, Xu B, Zhang YM. Efficacy of whole-lung lavage in treatment of pulmonary alveolar proteinosis. Am J Ther. 2016;23(6):e1671\u20139. https:\/\/doi.org\/10.1097\/MJT.0000000000000239.","journal-title":"Am J Ther"},{"issue":"6","key":"2906_CR47","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1378\/chest.09-2295","volume":"136","author":"G Michaud","year":"2009","unstructured":"Michaud G, Reddy C, Ernst A. Whole-lung lavage for pulmonary alveolar proteinosis. Chest. 2009;136(6):1678\u201381. https:\/\/doi.org\/10.1378\/chest.09-2295.","journal-title":"Chest"},{"issue":"4","key":"2906_CR48","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1183\/09031936.04.00102704","volume":"23","author":"M Beccaria","year":"2004","unstructured":"Beccaria M, Luisetti M, Rodi G, Corsico A, Zoia MC, Colato S, et\u00a0al. Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. Eur Respir J. 2004;23(4):526\u201331. https:\/\/doi.org\/10.1183\/09031936.04.00102704.","journal-title":"Eur Respir J"},{"key":"2906_CR49","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1913590","author":"BC Trapnell","year":"2020","unstructured":"Trapnell BC, Inoue Y, Bonella F, Morgan C, Jouneau S, Bendstrup E, et\u00a0al. Inhaled molgramostim therapy in autoimmune pulmonary alveolar proteinosis. N Engl J Med. 2020. https:\/\/doi.org\/10.1056\/NEJMoa1913590.","journal-title":"N Engl J Med"},{"issue":"4","key":"2906_CR50","doi-asserted-by":"publisher","first-page":"L556","DOI":"10.1152\/ajplung.1999.276.4.L556","volume":"276","author":"JA Reed","year":"1999","unstructured":"Reed JA, Ikegami M, Cianciolo ER, Lu W, Cho PS, Hull W, et\u00a0al. Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice. Am J Physiol. 1999;276(4):L556\u201363. https:\/\/doi.org\/10.1152\/ajplung.1999.276.4.L556.","journal-title":"Am J Physiol"},{"issue":"10","key":"2906_CR51","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1056\/NEJMoa1816216","volume":"381","author":"R Tazawa","year":"2019","unstructured":"Tazawa R, Ueda T, Abe M, Tatsumi K, Eda R, Kondoh S, et\u00a0al. Inhaled GM-CSF for pulmonary alveolar proteinosis. N Engl J Med. 2019;381(10):923\u201332. https:\/\/doi.org\/10.1056\/NEJMoa1816216.","journal-title":"N Engl J Med"},{"issue":"5","key":"2906_CR52","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1378\/chest.11-0951","volume":"141","author":"A Khan","year":"2012","unstructured":"Khan A, Agarwal R, Aggarwal AN. Effectiveness of granulocyte-macrophage colony-stimulating factor therapy in autoimmune pulmonary alveolar proteinosis: a meta-analysis of observational studies. Chest. 2012;141(5):1273\u201383. https:\/\/doi.org\/10.1378\/chest.11-0951.","journal-title":"Chest"},{"issue":"8","key":"2906_CR53","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1513\/AnnalsATS.201611-892BC","volume":"14","author":"S Ohkouchi","year":"2017","unstructured":"Ohkouchi S, Akasaka K, Ichiwata T, Hisata S, Iijima H, Takada T, et\u00a0al. Sequential granulocyte-macrophage colony-stimulating factor inhalation after whole-lung lavage for pulmonary alveolar proteinosis. A report of five intractable cases. Ann Am Thorac Soc. 2017;14(8):1298\u2013304. https:\/\/doi.org\/10.1513\/AnnalsATS.201611-892BC.","journal-title":"Ann Am Thorac Soc."},{"issue":"1","key":"2906_CR54","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12931-018-0862-4","volume":"19","author":"G Sheng","year":"2018","unstructured":"Sheng G, Chen P, Wei Y, Chu J, Cao X, Zhang HL. Better approach for autoimmune pulmonary alveolar proteinosis treatment: inhaled or subcutaneous granulocyte-macrophage colony-stimulating factor: a meta-analyses. Respir Res. 2018;19(1):163. https:\/\/doi.org\/10.1186\/s12931-018-0862-4.","journal-title":"Respir Res"},{"issue":"12","key":"2906_CR55","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1164\/rccm.200906-0978OC","volume":"181","author":"R Tazawa","year":"2010","unstructured":"Tazawa R, Trapnell BC, Inoue Y, Arai T, Takada T, Nasuhara Y, et\u00a0al. Inhaled granulocyte\/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis. Am J Respir Crit Care Med. 2010;181(12):1345\u201354. https:\/\/doi.org\/10.1164\/rccm.200906-0978OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"2906_CR56","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1183\/09031936.00197710","volume":"38","author":"MS Kavuru","year":"2011","unstructured":"Kavuru MS, Malur A, Marshall I, Barna BP, Meziane M, Huizar I, et\u00a0al. An open-label trial of rituximab therapy in pulmonary alveolar proteinosis. Eur Respir J. 2011;38(6):1361\u20137. https:\/\/doi.org\/10.1183\/09031936.00197710.","journal-title":"Eur Respir J"},{"issue":"1","key":"2906_CR57","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12931-018-0780-5","volume":"19","author":"B Soyez","year":"2018","unstructured":"Soyez B, Borie R, Menard C, Cadranel J, Chavez L, Cottin V, et\u00a0al. Rituximab for auto-immune alveolar proteinosis, a real life cohort study. Respir Res. 2018;19(1):74. https:\/\/doi.org\/10.1186\/s12931-018-0780-5.","journal-title":"Respir Res"},{"issue":"3","key":"2906_CR58","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1006\/clim.2002.5301","volume":"105","author":"TL Bonfield","year":"2002","unstructured":"Bonfield TL, Kavuru MS, Thomassen MJ. Anti-GM-CSF titer predicts response to GM-CSF therapy in pulmonary alveolar proteinosis. Clin Immunol. 2002;105(3):342\u201350. https:\/\/doi.org\/10.1006\/clim.2002.5301.","journal-title":"Clin Immunol"},{"issue":"5","key":"2906_CR59","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1183\/09031936.00097508","volume":"33","author":"M Luisetti","year":"2009","unstructured":"Luisetti M, Rodi G, Perotti C, Campo I, Mariani F, Pozzi E, et\u00a0al. Plasmapheresis for treatment of pulmonary alveolar proteinosis. Eur Respir J. 2009;33(5):1220\u20132. https:\/\/doi.org\/10.1183\/09031936.00097508.","journal-title":"Eur Respir J"},{"key":"2906_CR60","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12890-015-0085-0","volume":"15","author":"K Akasaka","year":"2015","unstructured":"Akasaka K, Tanaka T, Kitamura N, Ohkouchi S, Tazawa R, Takada T, et\u00a0al. Outcome of corticosteroid administration in autoimmune pulmonary alveolar proteinosis: a retrospective cohort study. BMC Pulm Med. 2015;15:88. https:\/\/doi.org\/10.1186\/s12890-015-0085-0.","journal-title":"BMC Pulm Med"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02906-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-021-02906-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02906-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:39Z","timestamp":1625788839000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-021-02906-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,9]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2906"],"URL":"https:\/\/doi.org\/10.1186\/s13256-021-02906-2","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,9]]},"assertion":[{"value":"4 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s father for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"340"}}